Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Endonuclease G interacts with histone H2B and DNA topoisomerase II alpha during apoptosis

M. Vařecha, M. Potěšilová, P. Matula, M. Kozubek,

. 2012 ; 363 (1-2) : 301-7.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK ProQuest Central from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2011-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-01-01 to 1 year ago

Apoptosis is a natural form of cell death involved in many physiological changes in the cell. Defects in the process of apoptosis can lead to serious diseases. During some apoptotic pathways, proteins apoptosis-inducing factor (AIF) and endonuclease G (EndoG) are released from the mitochondria and they translocate into the cell nuclei, where they probably participate in chromatin degradation together with other nuclear proteins. Exact mechanism of EndoG activity in cell nucleus is still unknown. Some interacting partners like flap endonuclease 1, DNase I, and exonuclease III were already suggested, but also other interacting partners were proposed. We conducted a living-cell confocal fluorescence microscopy followed by an image analysis of fluorescence resonance energy transfer to analyze the possibility of protein interactions of EndoG with histone H2B and human DNA topoisomerase II alpha (TOPO2a). Our results show that EndoG interacts with both these proteins during apoptotic cell death. Therefore, we can conclude that EndoG and TOPO2a may actively participate in apoptotic chromatin degradation. The possible existence of a degradation complex consisting of EndoG and TOPO2a and possibly other proteins like AIF and cyclophilin A have yet to be investigated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034834
003      
CZ-PrNML
005      
20121210094102.0
007      
ta
008      
121023s2012 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11010-011-1182-x $2 doi
035    __
$a (PubMed)22160858
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Vařecha, Miroslav $u Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Botanická 68a, 602 00 Brno, Czech Republic. mvara@fi.muni.cz
245    10
$a Endonuclease G interacts with histone H2B and DNA topoisomerase II alpha during apoptosis / $c M. Vařecha, M. Potěšilová, P. Matula, M. Kozubek,
520    9_
$a Apoptosis is a natural form of cell death involved in many physiological changes in the cell. Defects in the process of apoptosis can lead to serious diseases. During some apoptotic pathways, proteins apoptosis-inducing factor (AIF) and endonuclease G (EndoG) are released from the mitochondria and they translocate into the cell nuclei, where they probably participate in chromatin degradation together with other nuclear proteins. Exact mechanism of EndoG activity in cell nucleus is still unknown. Some interacting partners like flap endonuclease 1, DNase I, and exonuclease III were already suggested, but also other interacting partners were proposed. We conducted a living-cell confocal fluorescence microscopy followed by an image analysis of fluorescence resonance energy transfer to analyze the possibility of protein interactions of EndoG with histone H2B and human DNA topoisomerase II alpha (TOPO2a). Our results show that EndoG interacts with both these proteins during apoptotic cell death. Therefore, we can conclude that EndoG and TOPO2a may actively participate in apoptotic chromatin degradation. The possible existence of a degradation complex consisting of EndoG and TOPO2a and possibly other proteins like AIF and cyclophilin A have yet to be investigated.
650    _2
$a antigeny nádorové $x chemie $x genetika $x metabolismus $7 D000951
650    _2
$a apoptóza $7 D017209
650    _2
$a buněčné jádro $x enzymologie $x patologie $7 D002467
650    _2
$a restrukturace chromatinu $7 D042002
650    _2
$a DNA-topoisomerasy typu II $x chemie $x genetika $x metabolismus $7 D004250
650    _2
$a DNA vazebné proteiny $x chemie $x genetika $x metabolismus $7 D004268
650    _2
$a endodeoxyribonukleasy $x chemie $x genetika $x metabolismus $7 D004706
650    _2
$a rezonanční přenos fluorescenční energie $7 D031541
650    _2
$a HeLa buňky $7 D006367
650    _2
$a histony $x chemie $x genetika $x metabolismus $7 D006657
650    _2
$a lidé $7 D006801
650    _2
$a konfokální mikroskopie $7 D018613
650    _2
$a molekulární modely $7 D008958
650    _2
$a konformace proteinů $7 D011487
650    _2
$a interakční proteinové domény a motivy $7 D054730
650    _2
$a mapování interakce mezi proteiny $7 D025941
650    _2
$a rekombinantní fúzní proteiny $x metabolismus $7 D011993
650    _2
$a časové faktory $7 D013997
650    _2
$a transfekce $7 D014162
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Potěšilová, Michaela
700    1_
$a Matula, Pavel
700    1_
$a Kozubek, Michal
773    0_
$w MED00003385 $t Molecular and cellular biochemistry $x 1573-4919 $g Roč. 363, č. 1-2 (2012), s. 301-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22160858 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a
990    __
$a 20121023 $b ABA008
991    __
$a 20121210094138 $b ABA008
999    __
$a ok $b bmc $g 956844 $s 792331
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 363 $c 1-2 $d 301-7 $i 1573-4919 $m Molecular and cellular biochemistry $n Mol Cell Biochem $x MED00003385
LZP    __
$a Pubmed-20121023

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...